{"id":"W6968097576","doi":"10.5281/zenodo.15380122","title":"Perspectives and Insights on Antihemorrhagic Drugs: From Development to Submission of New Drug Submission (NDS) to Health Canada","year":2025,"lang":"en","type":"article","venue":"Zenodo (CERN European Organization for Nuclear Research)","topic":"Scientific Innovation and Industrial Efficiency","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Dosing; Clotting factor; Off-label use; Drug; Pharmacovigilance; Drug approval; Adverse effect; Drug development; Quality (philosophy)","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007782336,0.0007216848,0.0005934205,0.003535728,0.006142934,0.01660543,0.002318455,0.004886553,0.02522252],"category_scores_gemma":[0.01417595,0.0004598947,0.0008859927,0.003521818,0.007169557,0.004202104,0.002796635,0.004857772,0.002069983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1101052,"about_ca_system_score_gemma":0.2907311,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9173161,"about_ca_topic_score_gemma":0.9505198,"domain_scores_codex":[0.9874098,0.001475263,0.0005413028,0.0008732256,0.006565919,0.003134486],"domain_scores_gemma":[0.9744685,0.003282179,0.001488726,0.0002953861,0.01427927,0.006185818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004062473,0.0003318944,0.01458868,0.001775319,0.00006578062,0.001693007,0.002020205,0.001672055,0.003246916,0.2522126,0.3846076,0.3373796],"study_design_scores_gemma":[0.00006149298,0.0001916273,0.01667838,0.001777579,0.00005991043,0.0007072907,0.004028878,0.001288543,0.002096928,0.01867729,0.9542951,0.0001369833],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.015004,0.08787565,0.002730103,0.6968738,0.003158141,0.0002156091,0.001906032,0.0001700113,0.1920666],"genre_scores_gemma":[0.3571132,0.2690832,0.01340552,0.2477247,0.003471686,0.000158612,0.00203248,0.0002343387,0.1067763],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.1101052,"threshold_uncertainty_score":0.7988727,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08189828678990954,"score_gpt":0.3350733013520977,"score_spread":0.2531750145621882,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}